Go back to MDS Pharma Services home page


Quality results. On time.

With five facilities across North America and Europe, MDS Pharma Services is one of the largest global providers of early clinical research. We consistently deliver early-phase research with on-time study execution and high-quality data—from recruitment to conduct to final deliverables.

Consistent global processes and procedures guide our experienced staff, ensuring confidence in your study every step of the way. Our recruitment experience enables us to get your project started full and on time. Our worldwide presence gives you access to diverse populations and the ability to work effectively with local regulatory bodies. We also offer electronic tracking and data capture to speed report generation and ensure accuracy.

Our Phoenix site.

Our brand new, state-of-the-art clinical research facility in Phoenix, Arizona, offers comprehensive capabilities; a full clinical laboratory with the largest early phase clinical-bed capacity in the Western U.S. In response to clients’ increasing demand for clinical trials, we have expanded our Phoenix facility to 420 beds.Rapid study start-up—making way for earlier “go/no go” decisions.

Committed to starting your project on time, the first time
– Tracking to a greater than 97 percent on-time recruitment rate
– Access to a deep and diverse pool of study participants
– Specialized cardiac assessment/QTc studies to supply early cardiovascular risk analysis as part of your phase I trial to help make earlier “go/no go” decisions

Easy access
– Short frequent flights from California—our Phoenix clinic is ideally located to serve the West Coast biotech community
– Your staff can be present for study initiation, dosing, critical study conduct and monitoring, with minimal time away from their office and home

Full range of services.

From recruitment of healthy volunteers through delivery of high-quality results, MDS Pharma Services can provide a full range of services for your clinical trial needs. With strong expertise in high quality early clinical services, we conduct bioequivalence studies in conjunction with phase I trials—making MDS a one-stop solution for your early clinical research projects.

Our first-in-human program leverages MDS’ expertise in early-phase drug and biopharmaceutical development. Along with this, we offer program management, coordinated drug metabolism and pharmacokinetics (DMPK), toxicology, safety pharmacology and regulatory services to help you reach important milestones.

Watch Video

Early Clinical Research Services
- Riaz Bandali

Innovative Strategies for FIH Studies
- Robert F. Butz, Ph.D.

Thorough QTc Studies
-Bill Wheeler, MD, FACC &
Joy Olbertz, PharmD, PhD

Phase I Ophthalmic Clinical Studies
- Susan Orr, OD

Outsourcing Partnerships in Phase I
- Shashank Rohatagi, Ph.D., MBA, F.C.P.

Population PK Studies
- Nathan S. Teuscher, Ph.D.

Please click here
if you would like someone from MDS Pharma Services to contact you


© 2008 MDS Pharma Services     |     Corporate Governance     |     Legal     |     Privacy     |     Site Map